Wells Investment

Testworks is a social enterprise based in Seoul, Korea. It specializes in innovative solutions for AI data processing automation and software testing, while also promoting inclusivity by providing employment opportunities to socially disadvantaged individuals.

Anipen is a Korean company focused on developing 3D content and augmented reality applications tailored for short video platforms and video games. The firm utilizes advanced augmented reality and deep learning technologies to create engaging content, including AR web TV shows, promotional videos for social media, and animated clips optimized for mobile devices. By providing these innovative solutions, Anipen enables enterprises to enhance their video communication and entertainment offerings, thereby promoting their products effectively in a competitive digital landscape.

Ingine Inc. is a technology company based in Seoul, South Korea, founded in 2017. It specializes in the development of a wave energy converter known as INwave, which effectively transforms tidal energy generated from waves into electricity. This innovative technology is capable of operating in shallow waters, addressing the limitations faced by traditional converters. By harnessing the full range of wave movements, Ingine enables clients to generate power in environments where other solutions may not be viable, positioning itself as a significant player in the renewable energy sector focused on wave power generation.

Founded in 2016, Neurophet is a neuroscience company based in Seoul, South Korea. It specializes in developing advanced brain stimulation simulation software, Neurophet tES Lab, and neuro-navigation technology to aid clinicians in treating patients with brain diseases.

3billion is a Seoul-based company that provides genetic testing and analysis services for rare disease patients. Founded in 2016, it uses bioinformatics and machine learning to shorten and reduce the cost of genome interpretation, aiming to make genome-scale testing accessible for patients in need. The company develops AI-driven diagnostic tools and offers products such as 3B-GENOME, 3B-EXOME, 3B-VARIANT, and 3B-INTERPRETER to support comprehensive genetic analysis and faster diagnosis.

Medihere Inc. is a healthcare technology company based in Seoul, South Korea, founded in 2018. It specializes in providing online healthcare consultation services, enabling patients to connect with board-certified physicians who are fluent in both Korean and English. Medihere offers a subscription-based service that allows patients to schedule doctor's appointments and receive prescriptions through text-based or video consultations. The platform is particularly beneficial for individuals with chronic diseases or those facing language barriers when discussing their health concerns. Additionally, Medihere provides a B2B program that offers virtual primary care services to enterprises, facilitating remote consultations for employees. Through its innovative approach, Medihere aims to enhance accessibility and affordability in primary healthcare.

Ziptoss Co., Ltd., established in 2016 and based in Seoul, South Korea, operates an online platform that facilitates the search for rental properties in the country. The company's core business is to disrupt the South Korean real estate industry by offering a free brokerage service for tenants, providing transparent information, and charging reliable offline fees. Ziptoss's services include an application that offers online property listings, sales advertisements, and brokerage services for foreign tenants, all while directly sourcing data from landlords, enabling tenants to secure accommodations without incurring third-party fees.

Fount Inc. is an asset management Robo-Advisor company that was founded in 2015 and is headquartered in Seoul, South Korea. The firm specializes in providing customized financial portfolios through its investing algorithm, which leverages Big Data technology and advanced computer algorithms. Fount's Robo-Advisor engine, Bluewhale, determines the optimal combination of assets by integrating financial engineering technology with asset allocation theories. The company's approach emphasizes passive investing, aiming to align investment strategies with clients' goals and risk tolerances over various time horizons. By utilizing AI technology, Fount enables clients to effectively monitor financial markets and adjust their asset allocations in response to market changes.

CastingN Co., Ltd is a South Korean company that operates an online sourcing platform designed to connect businesses with professional subcontractors. Founded in 2015 and based in Incheon, the platform evaluates various factors such as company history, performance, recruitment history, and specialty fields to find suitable matches for outsourcing needs. CastingN facilitates a range of contracting jobs, including advertising, system development, web designing, accounting, and more, by linking companies with appropriate subcontractors from its registry. Additionally, it offers programs like job-oriented content development and offline job training to enhance the efficiency of business operations through specialized outsourcing.

3billion is a Seoul-based company that provides genetic testing and analysis services for rare disease patients. Founded in 2016, it uses bioinformatics and machine learning to shorten and reduce the cost of genome interpretation, aiming to make genome-scale testing accessible for patients in need. The company develops AI-driven diagnostic tools and offers products such as 3B-GENOME, 3B-EXOME, 3B-VARIANT, and 3B-INTERPRETER to support comprehensive genetic analysis and faster diagnosis.

Ziptoss Co., Ltd., established in 2016 and based in Seoul, South Korea, operates an online platform that facilitates the search for rental properties in the country. The company's core business is to disrupt the South Korean real estate industry by offering a free brokerage service for tenants, providing transparent information, and charging reliable offline fees. Ziptoss's services include an application that offers online property listings, sales advertisements, and brokerage services for foreign tenants, all while directly sourcing data from landlords, enabling tenants to secure accommodations without incurring third-party fees.

MDimune Inc. is a South Korean therapeutics company focused on developing innovative drug delivery systems. Founded in 2015 and based in Seoul, the company specializes in the creation of cancer therapeutics using immune cell-derived and stem cell-derived vesicles. Its research and development efforts encompass a range of therapeutic areas, including personalized cancer treatments, osteoarthritis, chronic obstructive pulmonary disease, and neurodegenerative disorders. MDimune's proprietary platform enables targeted delivery of drugs, allowing for the development of novel therapeutics that enhance treatment efficacy. The company provides its vesicle-based delivery solutions to biotech and pharmaceutical enterprises, thereby facilitating advanced therapeutic options for patients.

Perseus Inc. is a technology company that specializes in developing security software specifically for the automotive industry. Founded in 2016 and headquartered in Seoul, South Korea, with additional offices in San Jose, California, and Munich, Germany, Perseus focuses on enhancing automobile infrastructure security through its innovative hypervisor technology. This solution allows multiple applications and operating systems to operate on a single system-on-chip (SoC), significantly reducing the number of SoCs required in connected vehicles from an average of 120 to just 30, which can lead to cost savings of up to 75%. The company also provides a secure container that emulates the functionality of ARM TrustZone, ensuring dynamic protection for applications. Additionally, its Linux fast boot technology accelerates the startup time for embedded devices. Perseus's security solutions are designed to maintain high performance even under potential operating system attacks, offering fine-grained control over security parameters for enhanced protection.

3billion is a Seoul-based company that provides genetic testing and analysis services for rare disease patients. Founded in 2016, it uses bioinformatics and machine learning to shorten and reduce the cost of genome interpretation, aiming to make genome-scale testing accessible for patients in need. The company develops AI-driven diagnostic tools and offers products such as 3B-GENOME, 3B-EXOME, 3B-VARIANT, and 3B-INTERPRETER to support comprehensive genetic analysis and faster diagnosis.

MOIN is a blockchain-based global money transfer company that enables customers to send funds abroad. Headquartered in Seoul, South Korea, it focuses on Asia and offers an online platform for user-centric international remittances built on blockchain technology, aiming to provide fast, convenient, and reasonably priced transfers.

MOIN is a blockchain-based global money transfer company that enables customers to send funds abroad. Headquartered in Seoul, South Korea, it focuses on Asia and offers an online platform for user-centric international remittances built on blockchain technology, aiming to provide fast, convenient, and reasonably priced transfers.

G+FLAS Life Sciences is an agricultural biotechnology company focused on genome editing technologies for crops and health-related applications. It develops glycoengineered plants using CRISPR-PLUS to selectively remove glycosylation-related genes and provides gene-editing delivery methods into plant protoplasts. The company also pursues development of novel seeds and gene therapy drugs based on CRISPR-Cas, and operates plant cultivation facilities to support pharmaceutical and anticancer R&D. In addition to crop improvements, G+FLAS has explored nutritionally enhanced foods, including vitamin D3-enriched tomatoes, and has pursued strategic partnerships to scale commercialization, such as collaborations with large industry players to enable broader adoption of its technology. Through its integrated approach spanning plant biotechnology and therapeutic research, G+FLAS Life Sciences aims to advance sustainable agriculture and novel drug development.